Published date: 15 January 2020
This notice was replaced on 21 May 2020
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Awarded contract (published 21 May 2020)
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
North East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West
Value of contract
£125,000,000
Procurement reference
tender_228074/823415
Published date
15 January 2020
Closing date
17 February 2020
Contract start date
1 April 2020
Contract end date
31 March 2022
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
NHS Framework Agreement for Adalimumab Injection
Offer reference number: CM/PHR/19/5575
Period of Framework Agreement:
1 April 2020 - 31 March 2022 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
More information
Links
-
- https://nhsengland.bravosolution.co.uk
- Tender notice
- Link to eSourcing Portal
About the buyer
Contact name
Katie Noonan
Address
2nd Floor, Rutland House
Runcorn
WA7 2ES
England
Share this notice
All content is available under the
